A prospective study of risk factors for in-hospital mortality in patients with malignant obstructive jaundice undergoing percutaneous biliary drainage.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
Apr 2019
Historique:
entrez: 16 4 2019
pubmed: 16 4 2019
medline: 23 4 2019
Statut: ppublish

Résumé

The in-hospital mortality rate in patients undergoing percutaneous transhepatic biliary drainage (PTBD) for malignant obstructive jaundice (MOJ) is high. There are few reports on the risk factors associated with hospital death after MOJ, with most of them being retrospective analyses of single factors. Therefore, this study aimed to assess pre-, intra-, and post-procedure risk factors that were independently associated with increased in-hospital mortality in MOJ patients who underwent PTBD. One-hundred fifty-five patients with MOJ who underwent initial PTBD were included in this study. A total of 25 pre-, 4 intra-, and 6 post-procedure factors potentially related to in-hospital mortality were assessed by univariate and multivariate analyses. The in-hospital mortality rate was 16.8% (26/155). Of 25 pre-procedure variables analyzed, Child-Pugh classification C, creatinine level ≥6.93 μmol/L, and quality-of-life score (≤30) were found to be significant in univariate and multivariate analyses. Increased mortality was observed in patients with 2 or more risk factors, which was significantly different from patients with no risk factors or one risk factor (P < .01). None of the intra-procedure factors were important in identifying patients at risk of death. Multivariate analysis indicated post-PTBD cholangitis and unsuccessful drainage as post-procedure risk factors that correlated with in-hospital death. It was identified that in-hospital mortality was associated with 3 pre-procedure and 2 post-procedure risk factors, such as the liver function classification, quality-of-life score of cancer patients, creatinine level, PTBD-associated biliary duct infection, and unsuccessful drainage.

Sections du résumé

BACKGROUND BACKGROUND
The in-hospital mortality rate in patients undergoing percutaneous transhepatic biliary drainage (PTBD) for malignant obstructive jaundice (MOJ) is high. There are few reports on the risk factors associated with hospital death after MOJ, with most of them being retrospective analyses of single factors. Therefore, this study aimed to assess pre-, intra-, and post-procedure risk factors that were independently associated with increased in-hospital mortality in MOJ patients who underwent PTBD.
METHODS METHODS
One-hundred fifty-five patients with MOJ who underwent initial PTBD were included in this study. A total of 25 pre-, 4 intra-, and 6 post-procedure factors potentially related to in-hospital mortality were assessed by univariate and multivariate analyses.
RESULTS RESULTS
The in-hospital mortality rate was 16.8% (26/155). Of 25 pre-procedure variables analyzed, Child-Pugh classification C, creatinine level ≥6.93 μmol/L, and quality-of-life score (≤30) were found to be significant in univariate and multivariate analyses. Increased mortality was observed in patients with 2 or more risk factors, which was significantly different from patients with no risk factors or one risk factor (P < .01). None of the intra-procedure factors were important in identifying patients at risk of death. Multivariate analysis indicated post-PTBD cholangitis and unsuccessful drainage as post-procedure risk factors that correlated with in-hospital death.
CONCLUSION CONCLUSIONS
It was identified that in-hospital mortality was associated with 3 pre-procedure and 2 post-procedure risk factors, such as the liver function classification, quality-of-life score of cancer patients, creatinine level, PTBD-associated biliary duct infection, and unsuccessful drainage.

Identifiants

pubmed: 30985679
doi: 10.1097/MD.0000000000015131
pii: 00005792-201904120-00040
pmc: PMC6485810
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e15131

Références

Rofo. 2001 Dec;173(12):1072-8
pubmed: 11740666
Rev Gastroenterol Mex. 2006 Jan-Mar;71(1):22-30
pubmed: 17063571
Gut. 1983 Sep;24(9):845-52
pubmed: 6604001
Acta Radiol. 2003 Mar;44(2):139-46
pubmed: 12694096
Eur J Gastroenterol Hepatol. 2000 Oct;12(10):1095-100
pubmed: 11057454
Hepatobiliary Pancreat Dis Int. 2008 Oct;7(5):515-9
pubmed: 18842499
J Hepatol. 2005;42 Suppl(1):S100-7
pubmed: 15777564
Eur Radiol. 2017 Oct;27(10):4291-4297
pubmed: 28349279
Eur Radiol. 2008 Mar;18(3):448-56
pubmed: 17960388
Endoscopy. 2017 Jun;49(6):544-548
pubmed: 28196389
Surg Laparosc Endosc Percutan Tech. 2018 Apr;28(2):133
pubmed: 29613967
J Gastrointest Surg. 2009 Apr;13(4):814-20
pubmed: 18726134
Atherosclerosis. 2017 Oct;265:155-161
pubmed: 28892712
Medicine (Baltimore). 2017 Jan;96(3):e5895
pubmed: 28099348
Br J Surg. 2005 Nov;92(11):1388-92
pubmed: 16078295
Surg Endosc. 2010 Feb;24(2):423-31
pubmed: 19565296
Gastrointest Endosc. 2003 Jul;58(1):41-9
pubmed: 12838219
Lancet Oncol. 2017 Feb;18(2):e101-e112
pubmed: 28214411
Chin Med J (Engl). 2003 Jun;116(6):888-92
pubmed: 12877801
N Engl J Med. 2004 Apr 15;350(16):1646-54
pubmed: 15084697
Br J Surg. 1993 Sep;80(9):1185-7
pubmed: 7691375
Asian Pac J Cancer Prev. 2015;16(6):2543-6
pubmed: 25824794
J Clin Gastroenterol. 2009 Jul;43(6):580-5
pubmed: 19197195
Am J Surg. 1981 Jan;141(1):66-72
pubmed: 6970004
Br J Surg. 1983 Sep;70(9):535-8
pubmed: 6616158

Auteurs

Junfeng Sha (J)

Department of Interventional treatment, Qinhuangdao Municipal No. 1 Hospital, No. 258 Wenhua Road, Qinhuangdao, Hebei Province, PR China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH